Browsing Tag
diagnostics
13 posts
Gadoquatrane heads to FDA: Can Bayer lead the next generation of low-dose MRI contrast agents?
Bayer targets FDA nod for gadoquatrane, the lowest‑dose macrocyclic MRI contrast agent, potentially reshaping radiology practices globally.
June 17, 2025
Human Parvovirus B19: Understanding its rising impact on public health
Human parvovirus B19, discovered in the 1970s, has become a significant concern in public health, particularly due to…
August 15, 2024
PerkinElmer to acquire Oxford Immunotec for $591m to expand tuberculosis testing capabilities
In a significant move within the diagnostics sector, US-based PerkinElmer has announced its agreement to acquire UK-based Oxford…
January 16, 2021